On  December 10, 2013, FDA is conducting a public meeting on Patient-Focused Drug Development for fibromyalgia. FDA is interested in obtaining patient input on the impact of fibromyalgia on daily life and patients’ views on currently available therapies to treat the condition.


This website will be updated as registration and additional meeting information become available.


Date:  December 10, 2013 
Time:  1:00 p.m. to 5:00 p.m. 
Location: FDA White Oak Campus
10903 New Hampshire Ave.
Building 31, Room 1503A (Great Room)
Silver Spring, MD 20993
(Information about arrival to FDA’s White Oak campus)  
To register for this meeting, visit: https://patientfocusedfibromyalgia.eventbrite.com.
Registration will close on November 27, 2013.